Abstract |
The transforming growth factor β (TGFβ) pathway plays critical roles during cancer cell epithelial-mesenchymal transition (EMT) and metastasis. SMAD7 is both a transcriptional target and a negative regulator of TGFβ signalling, thus mediating a negative feedback loop that may potentially restrain TGFβ responses of cancer cells. Here, however, we show that TGFβ treatment induces SMAD7 transcription but not its protein level in a panel of cancer cells. Mechanistic studies reveal that TGFβ activates the expression of microRNA-182 (miR-182), which suppresses SMAD7 protein. miR-182 silencing leads to SMAD7 upregulation on TGFβ treatment and prevents TGFβ-induced EMT and invasion of cancer cells. Overexpression of miR-182 promotes breast tumour invasion and TGFβ-induced osteoclastogenesis for bone metastasis. Furthermore, miR-182 expression inversely correlates with SMAD7 protein in human tumour samples. Therefore, our data reveal the miR-182-mediated disruption of TGFβ self-restraint and provide a mechanism to explain the unleashed TGFβ responses in metastatic cancer cells.
|
Authors | Jingyi Yu, Rong Lei, Xueqian Zhuang, Xiaoxun Li, Gang Li, Sima Lev, Miguel F Segura, Xue Zhang, Guohong Hu |
Journal | Nature communications
(Nat Commun)
Vol. 7
Pg. 13884
(12 20 2016)
ISSN: 2041-1723 [Electronic] England |
PMID | 27996004
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- MicroRNAs
- Mirn182 microRNA, human
- SMAD7 protein, human
- Smad7 Protein
- Transforming Growth Factor beta
|
Topics |
- Animals
- Breast Neoplasms
(genetics, metabolism, pathology)
- Cell Line, Tumor
- Epithelial-Mesenchymal Transition
(genetics, physiology)
- Female
- Humans
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- MicroRNAs
(genetics, metabolism)
- Neoplasm Invasiveness
(genetics, pathology)
- Neoplasm Metastasis
(genetics, pathology)
- RNA Interference
- Signal Transduction
- Smad7 Protein
(genetics, metabolism)
- Transcriptional Activation
- Transforming Growth Factor beta
(metabolism)
|